Protara Therapeutics (TARA)
(Real Time Quote from BATS)
$3.11 USD
0.00 (0.00%)
Updated Aug 7, 2025 10:02 AM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Protara Therapeutics, Inc. has a market cap of $119.99M, which represents its share price of $3.11 multiplied by its outstanding shares number of 38.58M. As a small-cap company, TARA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TARA 3.11 0.00(0.00%)
Will TARA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TARA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TARA
Protara Therapeutics (TARA) Moves to Buy: Rationale Behind the Upgrade
TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy
TARA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TARA
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ...
Catalio Capital Management Raises Over $400M to Invest in Innovative Healthcare Companies in ...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ...
Protara Therapeutics (TARA) Added to Russell 3000 Index
Protara Therapeutics added to the Russell 3000 index